Pay in 4 interest-free payments of $5.33 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
R., Gorgian, P., Askari, G., Tarrahi, M
As of April 2026, retatrutide (LY3437943) remains an investigational drug in Phase 3 clinical trials
In 34 out of 49 patients meaningful fits could be obtained (Figure 3) (see Supplementary Information, Section 5.2 for further details, Figures S15S23 in File S1 for each the individual fits and Section 5.3, Figures S24S25 in File S1 for the fits grouped into the two age groups, above and below 40)
CJC1295 provides extended duration of action through its drug affinity complex (DAC) modification, allowing for sustained research observations over longer periods
US$ 26.64
US$ 26.58
US$ 21.88
US$ 23.54
